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Abstract EVective immune responses depend on the rec-
ognition of pathogens by dendritic cells (DCs) through pat-
tern recognition receptors (PRRs). These receptors induce
speciWc signaling pathways that lead to the induction of
immune responses against the pathogens. It is becoming
evident that C-type lectins are also important PRRs. In par-
ticular, the C-type lectin DC-SIGN has emerged as a key
player in the induction of immune responses against numer-
ous pathogens by modulating TLR-induced activation.
Recent reports have begun to elucidate the molecular mech-
anisms underlying these immune responses. Upon pathogen
binding, DC-SIGN induces an intracellular signaling path-
way with a central role for the serine/threonine kinase Raf-1.
For several pathogens that interact with DC-SIGN, including
Mycobacterium tuberculosis and HIV-1, Raf-1 activation
leads to acetylation of NF-B subunit p65, which induces
speciWc gene transcription proWles. In addition, other
DC-SIGN-ligands induce diVerent signaling pathways
downstream of Raf-1, indicating that DC-SIGN-signaling is
tailored to the pathogen. In this review we will discuss in
detail the current knowledge about DC-SIGN signaling and
its implications on immunity.
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Introduction
EVective immune responses depend on the recognition of
pathogens by dendritic cells (DCs) through pattern recog-
nition receptors (PRRs) [23]. These PRRs recognize so-
called pattern associated molecular patterns (PAMPs),
which are conserved groups of molecules from pathogens
that are essential for microbial survival, such as bacterial
or fungal cell wall components and viral or bacterial
nucleic acids [23]. DCs are equipped with several diVer-
ent classes of PPRs that recognize distinct PAMPs
expressed by pathogens. These diVerent classes of PRRs
include the Toll-like receptors (TLRs), NOD-like family
receptors and CARD helicases. Activation of these recep-
tors induces receptor-speciWc intracellular signals that
regulate the expression of response genes, such as those
encoding co-stimulatory molecules and cytokines and
chemokines.
Most pathogens express diVerent PAMPs and trigger
several classes of PRRs on a single cell simultaneously. As
a result, the ultimate expression of response genes induced
by a pathogen depends on the integration of these diVerent
signaling pathways. In fact, cross-talk between or even
within groups of PRRs is crucial in balancing immune
responses through collaborative induction of positive or
negative feedback mechanisms [27].
In recent years C-type lectins have emerged as PRRs that
play key roles in the induction of immune responses against
numerous pathogens. The C-type lectins DC-speciWc
ICAM-3 grabbing non-integrin (DC-SIGN) and DC-associ-
ated C-type lectin-1 (Dectin-1) both shape immune
responses against various pathogens. The intracellular sig-
naling pathways induced by these C-type lectins modulate
the responses of other PRRs such as TLRs, but also exert
functions independent from other PRRs [45].
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including (myco)bacteria, fungi, and viruses. Although
the interaction of DC-SIGN with pathogens signiWcantly
aVects the induction of immune responses [44], the molecu-
lar mechanisms that underlie DC-SIGN functions have
remained elusive for years. Recently, several studies have
shed light on the intracellular signaling pathways through
which DC-SIGN shapes immune responses [18, 21, 22]. In
this review we will discuss DC-SIGN signaling, with a
major role for the mechanism of cross-talk between DC-SIGN
and TLRs.
Immunomodulation by DC-SIGN
DC-SIGN is a calcium-dependent carbohydrate-binding
protein expressed by DCs [15] and macrophage subpopula-
tions [17] with a wide range of immunological functions.
DC-SIGN acts as an adhesion receptor that interacts with
ICAM-2 on endothelial cells to induce tethering and trans-
endothelial migration of DCs [12] and mediates clustering
of DCs with naive T cells through binding of ICAM-3 [15].
In addition, DC-SIGN functions as a PRR that induces spe-
ciWc immune responses upon interaction with numerous
pathogens [44]. DC-SIGN binds distinct carbohydrate
structures such as mannose-containing glycoconjugates
[30] and fucose-containing blood-group antigens [1]. This
carbohydrate recognition pattern is the basis of its broad
speciWcity for diVerent pathogens and might also be respon-
sible for its distinct signaling properties.
Mycobacteria target DC-SIGN to aVect TLR4-mediated
immune responses by impairing DC-maturation and enhanc-
ing IL-10 production [14]. Similarly, DC-SIGN binding to
the Lewis antigens on LPS from Helicobacter pylori induces
IL-10 production but inhibits Th1 polarization [3]. In con-
trast, LPS from Neisseria meningitidis mutants skews T
cells toward a Th1 response by binding to DC-SIGN [41]. In
addition, DC-SIGN binding by speciWc Lactobacilli species
induces regulatory T cell diVerentiation [40]. As binding of
DC-SIGN by diVerent pathogens results in distinct immuno-
logical outcomes, these Wndings support an important role
for DC-SIGN as an immunomodulator.
Several mechanisms have been suggested to account for
the observed modulation of TLR activation by DC-SIGN.
Co-localization of DC-SIGN with TLR4 could result in
enhanced TLR4 signaling, as has been described previously
for SIGNR1, a murine homolog of DC-SIGN [31]. In con-
trast, DC-SIGN has been hypothesized to induce intracellu-
lar signaling itself that converges with signaling pathways
of other PRRs.
Recent studies on the interaction of mycobacteria with
DCs have shed some light on the molecular mechanisms
that underlie DC-SIGN-mediated immune responses.
Mycobacteria such as Mycobacterium tuberculosis interact
with DCs through various receptors, including TLRs and
C-type lectins. TLR-triggering by mycobacteria induces
DC maturation and the induction of speciWc cytokines.
However, in addition to TLRs, mycobacteria also interact
with DCs by binding to DC-SIGN. One of the main ligands
responsible for mycobacterial binding to DC-SIGN is Man-
LAM [14], a cell wall component abundantly expressed by
pathogenic mycobacterial species such as M. tuberculosis.
The interaction of ManLAM with DC-SIGN increases the
production of the immunosuppressive cytokine IL-10 [14].
By screening with a large panel of inhibitors [18], it was
found that upon binding of ManLAM, DC-SIGN triggers
an intracellular signaling cascade independent from other
PRRs. Pivotal to DC-SIGN-signaling is the activation of
serine/threonine kinase Raf-1. Ligand binding leads to acti-
vation of Raf-1 and inhibition of Raf-1 completely blocks
DC-SIGN-mediated immune responses to mycobacteria. In
the next paragraphs, we will discuss DC-SIGN signaling in
detail. For clarity, we will Wrst focus on the upstream signal
transduction pathways that lead to Raf-1 activation; subse-
quently, we will discuss DC-SIGN signaling downstream
of Raf-1 and how this leads to modulation of immune
responses.
DC-SIGN signaling upstream of Raf-1
How binding of ManLAM or other ligands to DC-SIGN
leads to the initiation of intracellular signaling is still
unclear. DC-SIGN displays several motifs in its cytoplas-
mic tail that theoretically could be involved in the induction
of intracellular signaling pathways. Two motifs, a di-leu-
cine-based motif and a tri-acidic (Glu–Glu–Glu) cluster, are
known to be required for internalization [8]. In addition,
DC-SIGN bears a YxxL motif in its cytoplasmic tail, which
is known to be required for signaling of two other C-type
lectins, Dectin-1 and CLEC-2 [9, 11, 35]. However,
although it could play a role in the induction of other intra-
cellular signals [21], the tyrosine motif of DC-SIGN is not
essential for the activation of Raf-1 [18]. In addition, both
the tyrosine and the di-leucine motif are required for the
association of the cytoplasmic tail of DC-SIGN with leuko-
cyte speciWc protein 1 (LSP1), an F-actin binding protein
[39]. However, LSP1 has not been established to play a role
in signaling, but has been shown to mediate DC-SIGN-
dependent transport of HIV-1 to proteasomes [39]. Cluster-
ing of DC-SIGN-molecules could also play an important
role in the induction of intracellular signals. DC-SIGN
forms tetramers [30], which might allow the binding of
adaptor-molecules that can bridge the cytoplasmic tails of
two or more DC-SIGN molecules, as has been hypothe-
sized for Dectin-1 signaling [35]. Taken together, the123
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signal transduction is still highly speculative.
Currently, our knowledge of upstream DC-SIGN-signal-
ing begins with the direct upstream mediators of Raf-1
(Fig. 1). A prerequisite for Raf-1 activation is its interaction
with the active form of Ras, which induces a conforma-
tional change in Raf-1. Ras is a small G protein that can
mediate signaling by binding and hydrolysing GTP; the
GTP-bound form of Ras is active and capable of binding
Raf-1, whereas the GDP-bound form is inactive [48].
Indeed, the binding of ManLAM induces the GTP-bound
and active form of Ras through a yet to be identiWed Ras
guanine exchange factor (GEF). Also, inhibition of Ras
function prevents DC-SIGN-induced upregulation of cyto-
kines [18]. However, interaction between Raf-1 and GTP-
Ras alone is insuYcient to activate the kinase activity of
Raf-1 and additional phosphorylation of Raf-1 is required.
Several phosphorylation sites on Raf-1 have been identiWed
that are involved in its kinase activity [48]. Two of these
phosphorylation sites are tyrosines 340/341 (Tyr340/341)
and serine 338 (Ser338) [48]. Phosphorylation of Tyr340/
341 on Raf-1 in response to DC-SIGN signaling is carried
out by a member of the Src family of tyrosine kinases [18],
most likely Lyn, Hck or Fgr, which are the most abundant
Src kinases in DCs [28]. Raf-1 phosphorylation on Ser338
is induced by p21-activated kinases (Paks) [48]. Paks are
known to be activated by either Rac1 or Cdc42, both small
GTPases from the Rho GTPase family [48]. Indeed, inhibi-
tion of Rho GTPases with toxin B blocks DC-SIGN-
induced phosphorylation of Raf-1 on Ser338 [18]. Interest-
ingly, HIV-1 binding to DC-SIGN activates yet another
Rho GTPase, RhoA, which is mediated via leukemia-asso-
ciated Rho GEF (LARG) [21]. Since HIV-1-induced
immune responses are dependent on Raf-1 [18], these data
suggest that phosphorylation of Raf-1 at residue Ser338 is
mediated via LARG-RhoA-dependent activation of Pak.
Thus, DC-SIGN induces the activation of three routes
that converge to activate Raf-1 (Fig. 1): activation of Ras
leads to binding to Raf-1 and induces conformational
changes that allow for subsequent phosphorylation of Raf-1
by Src and Pak kinases; Src kinases induce the phosphory-
lation of Raf-1 at residue Tyr340/341, whereas Rho
GTPase-dependent activation of Pak kinases results in
phosphorylation of Raf-1 at Ser338.
DC-SIGN signaling downstream of Raf-1
As described above, activation of Raf-1 is essential for DC-
SIGN-mediated immune responses. However, signaling
downstream of Raf-1 appears to be dependent on the spe-
ciWc DC-SIGN-ligand involved. For example, DC-SIGN
activation by a speciWc antibody denoted MR-1 results in
activation of extracellular signal-regulated kinase (ERK)
[5]. Although mitogen-activated protein kinase kinase
(MEK), which can activate ERK [25], is a well-character-
ized possible downstream eVector of Raf-1, it is unclear
whether MR-1 also activates Raf-1. In addition, some stud-
ies have shown that a C-type lectin interaction with HIV-1
[37] or a glycoprotein allergen [38] induces ERK activa-
tion, although direct involvement of DC-SIGN has not been
demonstrated in these studies. In contrast, other reports
have demonstrated that binding of pathogenic ligands to
DC-SIGN does not lead to activation of ERK [18, 22].
Hence, ERK activation might be dependent on the ligand
binding to DC-SIGN, although certain contaminants in the
ligand preparations might also explain some of these diVer-
ential eVects. Nevertheless, for most pathogens including
M. tuberculosis and HIV-1, interaction with DC-SIGN
modulates immune responses by targeting nuclear factor-
B (NF-B). An exception is DC-SIGN-ligand Salp15,
which will be discussed separately in a paragraph below.
NF-B activation is crucial for the induction of DC-
mediated immune responses [32]. The NF-B family is
composed of several subunits that can form homodimers
and heterodimers. The most abundant and prototypical
form of NF-B is a heterodimer between p65 and p50, of
which p65 is the transcriptionally active component. In
unstimulated cells, p65 is inactive and resides primarily in
the cytosol in complex with any of the inhibitory IB pro-
teins. Upon stimulation, the IB proteins are degraded and
the p65–p50 dimers translocate into the nucleus where they
bind to target DNA sequences to inXuence gene expression.
Several classes of PRRs induce the activation of NF-B
after pathogen recognition. For example, TLR triggering
leads to p65 activation via both MyD88- and TRIF-depen-
dent pathways [42], which induces the transcription of
numerous target genes including cytokines and chemo-
kines.
The activity of p65 is regulated by several post-transla-
tional modiWcations such as phosphorylation and acetyla-
tion [20]. Strikingly, DC-SIGN-signaling controls p65
activity by phosphorylation of p65 at serine 276 (Ser276),
which is completely dependent on Raf-1-activation [18].
Subsequently, phosphorylation of p65 at Ser276 leads to
acetylation of p65. Acetylation of p65 can be mediated by
two histone acetyltransferases (HATs), CREB binding pro-
tein (CBP) and p300, which in human DCs show high con-
stitutive activity (unpublished data). Acetylation is known
to have major consequences for p65 activity [20]. DC-
SIGN-mediated acetylation of p65 leads to both increased
and prolonged transcription from the IL10 promoter, result-
ing in a strongly increased production of IL-10 by DCs
[18].
Crucial for the understanding of DC-SIGN-signaling and
its eVect on immune responses is that DC-SIGN cannot123
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when activation of p65 has been induced by another recep-
tor. The induction of DC-SIGN-signaling by the mycobac-
terial component ManLAM does not induce activation of
p65, and therefore does not induce any cytokine responses.
However, upon stimulation with whole mycobacteria,
TLR4 and TLR2 triggering induce the activation and trans-
location of p65 to the nucleus, which allows for subsequent
phosphorylation and acetylation of p65 by DC-SIGN sig-
naling (Fig. 1).
A question that remains unanswered is the identity of the
kinase responsible for phosphorylation of Ser276 of p65
upon DC-SIGN triggering. A number of kinases have pre-
viously been reported to phosphorylate Ser276 on p65,
including protein kinase A (PKA) and the related mitogen-
and stress-activated kinase-1 (MSK1) [47, 49], but inhibi-
tors against these kinases do not inhibit ManLAM-induced
IL-10 upregulation [18]. Hence, the identity of this kinase
is still under investigation.
DC-SIGN-mediated modulation of immune responses 
to pathogens
In addition to several mycobacterial species including
M. tuberculosis, M. bovis BCG and M. leprae, DC-SIGN-
signaling is induced by several other classes of pathogens.
Yeasts (Candida albicans and Saccharomyces cerevisiae)
and viruses (HIV-1 and measles virus) also induce the Raf-
1 pathway through DC-SIGN to modulate TLR responses
[18]. This underscores that DC-SIGN has an important role
in the regulation of DC-mediated immune responses to
Fig. 1 DC-SIGN signaling by 
mycobacteria, viruses and fungi. 
Binding of several pathogens 
including M. tuberculosis, 
C. albicans and HIV-1 to 
DC-SIGN activates three routes 
that converge to activate Raf-1: 
activation of Ras leads to binding 
to Raf-1 and induces conforma-
tional changes that allow for 
subsequent phosphorylation 
of Raf-1 by Src and Pak kinases; 
Src kinases induce the phosphor-
ylation of Raf-1 at residue 
Tyr340/341, whereas Rho 
GTPase-dependent activation 
of Pak kinases results in phos-
phorylation of Raf-1 at Ser338. 
After translocation of NF-B 
by TLR-stimulation, DC-SIGN-
induced Raf-1 activation 
mediates the phosphorylation 
of NF-B subunit p65 at Ser276, 
which in turn leads to p65-acety-
lation. Acetylation of p65 both 
prolongs and increases IL-10 
transcription, resulting in 
increased IL-10 production123
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lation of NF-B activation only occurs when a pathogen
triggers DC-SIGN simultaneously with another receptor
that activates NF-B. For example, mycobacteria such as
M. tuberculosis and M. bovis BCG activate NF-B through
TLR2 and TLR4 activation, while viruses activate NF-B
via TLR3 and TLR7/8 triggering in endosomes [6]. How-
ever, the modulation of immune responses by DC-SIGN is
probably not restricted to TLR-activation, but instead might
also include other NF-B dependent responses. Hypotheti-
cally, DC-SIGN signaling modulates the induction of any
immune response that is p65-dependent, since phosphoryla-
tion and acetylation of p65 drastically alter the transcription
rate, the duration of p65 activation and even the aYnity of
p65 with other proteins [20].
Additional investigations are required to determine how
DC-SIGN signaling aVects the immune response against a
speciWc pathogen in toto. Besides the immunosuppressive
cytokine IL-10, acetylation of p65 most likely modulates
the transcription of other, pro-inXammatory immune genes
as well, since the majority of cytokines induced by TLR-
stimulation in DCs depends at some level on NF-B activa-
tion. Therefore, the resulting net immune response induced
by DC-SIGN-signaling depends on the complete array of
cytokines that are modulated by p65-acetylation. Future
investigations will be required to determine whether
DC-SIGN-signaling dictates pro- or anti-inXammatory
responses or whether it directs a speciWc type of T cell
diVerentiation such as T helper 1, 2, 17 or regulatory T
cells.
Immunomodulation by salivary tick protein Salp15
While interaction with the previously described mycobacteria,
viruses and fungi with DC-SIGN leads to Raf-1-dependent
Fig. 2 DC-SIGN signaling by 
Salp15. Salp15 from tick saliva 
modulates immune responses to 
tick-transmitted pathogens such 
as B. burgdorferi. Salp15 bind-
ing to DC-SIGN activates Raf-1 
kinase similar as described for 
pathogens. However, in contrast 
to DC-SIGN-induced Raf-1 acti-
vation by pathogens, Salp15-
induced Raf-1 activation leads 
to activation of MEK. 
Salp15-induced Raf-1/MEK 
signaling regulates cytokine 
expression at diVerent levels: 
inhibition of IL-6 and TNF is 
caused by enhanced degradation 
of their respective mRNAs, 
while decreased production 
of IL-12 results from impaired 
nucleosome remodeling at the 
IL-12p35 promoter123
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ligand, Salp15, modulates TLR-activation on DCs through
a diVerent mechanism. Salp15 is an immunomodulatory
protein produced by the salivary glands of Ixodes scapu-
laris ticks [7]. The presence of immunosuppressive mole-
cules in tick saliva facilitate tick feeding, but also greatly
enhance the tick’s ability to transmit human pathogens such
as Borrelia burgdorferi [33], the causative agent of Lyme
disease.
Salp15 inhibits TLR2- and TLR4-induced production of
pro-inXammatory cytokines IL-12, IL-6 and TNF. Similar
to ManLAM, modulation of TLR-responses is completely
dependent on the activation of Raf-1 [22]. However, in con-
trast to ManLAM, Salp15-induced signaling does not lead
to phosphorylation or acetylation of p65, but instead to acti-
vation of MEK. The Salp15-induced Raf-1/MEK signaling
regulates the inhibition of pro-inXammatory cytokines at
diVerent levels: inhibition of IL-6 and TNF is caused by
enhanced degradation of their respective mRNAs, while
decreased production of IL-12 results from impaired nucle-
osome remodeling at the IL-12p35 promoter (Fig. 2) [22].
The reason behind the diVerent downstream eVectors of
Raf-1 after activation by Salp15 compared to ManLAM is
still unclear. One explanation could be that Salp15 also
activates other receptors, which modulate DC-SIGN signal-
ing. Besides DC-SIGN, Salp15 has also been described to
bind to CD4 [24]. Although no direct physical association
has been found between both proteins [4], DC-SIGN and
CD4 have been found to colocalize on the cell-surface [26].
On T cells, binding of Salp15 to CD4 modulates actin poly-
merization [24]. A central theme in signaling is bringing
together kinases and substrates, and impairment of actin
polymerization might bring Raf-1 together with a diVerent
downstream eVector compared to ManLAM-induced DC-
SIGN-signaling. Therefore, co-ligation of DC-SIGN and
CD4 by Salp15 might be responsible for the induction of
this distinct signaling pathway by aVecting the subcellular
localization of either Raf-1 or its downstream eVectors.
Additionally, future research on the molecular mechanism
of Salp15-induced DC immunosuppression is required to
elucidate how MEK aVects mRNA stability and nucleo-
some remodeling. Although MEK kinases are well known
to activate ERK 1 and 2, Salp15 does not signal through
ERK kinases [22]. The downstream eVectors of MEK are
most likely involved in post-translational modiWcations of
the proteins involved in mRNA decay and nucleosome
remodeling.
Thus, although Salp15 binding to DC-SIGN does induce
Raf-1 activation similar to ManLAM, the downstream
eVectors that modulate TLR-induced activation are diVer-
ent. This demonstrates that pathogen binding to DC-SIGN
might lead to diVerent ligand-speciWc signaling cascades
that regulate distinct adaptive immune responses. Although
Raf-1 seems to play a central role in DC-SIGN-induced
modulation of TLR-responses, the downstream eVectors of
Raf-1 regulate the subsequent cytokine responses.
Immune suppression and viral transmission by HIV-1
As described previously, binding of HIV-1 to DC-SIGN
modulates TLR activation via Raf-1 signaling [18]. How-
ever, DC-SIGN signaling by HIV-1 not only enhances
TLR-induced IL-10 production, but also impairs TLR-
induced dendrite formation of DCs and T cell proliferation
[21]. In addition, HIV-1-induced DC-SIGN signaling medi-
ates eVects independent of TLR activation. Microarray
studies revealed that cross-linking of DC-SIGN with an
antibody that mimics HIV-1-binding speciWcally aVected
the gene expression proWle of DCs, with hundreds of genes
being induced or downregulated after ligation [21]. One of
the most notable features of the DC-SIGN signaling pro-
gram is the induction of ATF3, a negative regulator of
TLR4 [16], suggesting that DC-SIGN signaling besides
modulating also represses TLR4 signaling.
Besides modulation of immune responses, DC-SIGN
signaling also plays an important role in the transmission of
viruses from DCs to T cells [13]. DCs capture HIV-1
through the high-aYnity interaction of DC-SIGN with
gp120, the HIV-1 envelope glycoprotein. Subsequently,
DCs are able to mediate transmission of the virus to T cells
through the formation of a so-called infectious synapse
between HIV-1-infected DCs and CD4+ T cells [29].
Recently, Hodges et al. [21] demonstrated that DC-SIGN-
induced signaling is responsible for viral synapse formation
between DCs and T cells. The authors found that binding of
HIV-1 to DC-SIGN on DCs induces LARG-mediated acti-
vation of the GTPase RhoA, which is required for viral syn-
apse formation. It will be interesting to investigate whether
RhoA activation by HIV-1 is also involved in the Raf-1-
dependent immune responses (Fig. 1). Taken together,
these Wndings suggest that the DC-SIGN signaling pathway
orchestrates several immunological functions of DCs ranging
from modulation of immune responses to the transmission
of viruses to T cells.
DC-SIGN signaling in context of other C-type lectins
The C-type lectin receptor family has been increasingly
appreciated as an important member of PRRs. However,
although most C-type lectins express several potential sig-
naling motifs in their cytoplasmic domains, the molecular
mechanisms underlying the C-type lectin functions are still
largely unknown. The current knowledge about the molecu-
lar mechanisms of C-type lectins seems to suggest that the123
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Recently, several studies have characterized the signaling
pathways of Dectin-1, a C-type lectin involved in innate
immune responses to fungal pathogens. Engagement of
Dectin-1 by fungal -glucans leads to activation of spleen
tyrosine kinase (Syk) [35], which is also induced upon liga-
tion of CLEC-2 [9], but not DC-SIGN [9, 18]. Subse-
quently, Syk activation by Dectin-1 induces caspase
recruitment domain 9 (Card9)-dependent activation of NF-
B [19] (for an extensive review on the mechanism of Dec-
tin-1 signaling see [34]). As a consequence the activation of
Dectin-1, in contrast to DC-SIGN signaling, directly leads
to the expression of cytokines independent from TLR acti-
vation.
However, DC-SIGN and Dectin-1 also mediate similar
functions. Analogous to DC-SIGN, Dectin-1 collaborates
with TLRs for the induction of cytokines [10]. The signal-
ing pathway underlying this cross-talk between Dectin-1
and TLRs remains to be identiWed, but seems to be inde-
pendent of Syk [10, 35]. Since DC-SIGN and Dectin-1 bear
common motifs in their cytoplasmic tail, this could suggest
that Dectin-1 might use similar signaling pathways for the
modulation of TLR responses. In addition, a recent study
reported that both Dectin-1 and DC-SIGN mediate the
induction of arachidonic acid [43]. Moreover, Dectin-1 was
found to associate with DC-SIGN, which was enhanced
upon stimulation with zymosan, a ligand for both Dectin-1
and DC-SIGN [43]. Since DC-SIGN and Dectin-1 are both
involved in the recognition of pathogens such as C. albi-
cans, co-localization of these two C-type lectins might add
additional variability to both DC-SIGN- and Dectin-1-
induced signaling cascades.
DC-SIGN signaling: beneWcial for host or pathogen?
DC-SIGN-signaling by pathogens does not modulate
immune responses in the same manner, but instead the
immune modulation depends on the pathogen involved.
These diVerences most likely result from the speciWc set of
PRRs that is activated. Every type of pathogen triggers a
speciWc set of PRRs, which are modulated diVerently by
DC-SIGN signaling. In addition, DC-SIGN itself might
induce diVerent signaling pathways depending on the DC-
SIGN ligand involved. However, a pivotal question that
remains is whether the DC-SIGN-induced modulation of
immune responses is beneWcial for the host or whether DC-
SIGN signaling is induced by pathogens to subvert an
eVective immune response and promote their growth and
survival.
In the case of HIV-1, DC-SIGN signaling appears to be
unambiguously beneWcial for the pathogen. DC-SIGN
signaling by HIV-1 impairs DC maturation, T cell prolifer-
ation and mediates the transmission of HIV-1 to T cells,
thereby promoting systemic infection of the host. In addi-
tion, for mycobacteria DC-SIGN signaling was initially
thought to be a mechanism through which DC function
was suppressed to promote pathogen survival, based on
impaired DC maturation and enhanced production of the
immunosuppressive cytokine IL-10 by DCs after stimula-
tion with ManLAM. However, this suppression might also
be beneWcial to the host by preventing excessive immune
activation. So far, genetic epidemiology has yielded con-
Xicting data. A recent study suggested that a single nucleo-
tide polymorphism (SNP) that leads to decreased DC-SIGN
expression is associated with reduced risk for cavitary
tuberculosis disease [46]; in contrast, SNPs in the DC-
SIGN promoter region that lead to increased DC-SIGN
expression appear to be protective against tuberculosis [2].
In addition, in a recent study it was reported that transgenic
mice expressing human DC-SIGN actually show enhanced
clearance of mycobacteria [36]. DCs from DC-SIGN-mice
displayed reduced tissue damage and prolonged survival.
These Wndings suggest that instead of favoring the immune
evasion of bacteria, DC-SIGN signaling may promote pro-
tection by limiting tuberculosis-induced pathology. How-
ever, remarkably, most DC-SIGN-binding pathogens are
microbes that in general induce latent infections, such as
M. tuberculosis, M. leprae, C. albicans and H. pylori. This
suggests that suppression of the immune response via inter-
action with DC-SIGN results in a “steady-state” that attenuates
immune-activation in order to limit detrimental side eVects
of a full-blown immune response, but in turn also allows
for pathogen survival.
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